# LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

> **NCT00161239** · NA · TERMINATED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 64 (estimated)

## Conditions studied

- T-Cell Lymphoma

## Interventions

- **DRUG:** Doxil, Methotrexate, L-Asparaginase, Prednisone

## Key facts

- **NCT ID:** NCT00161239
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-02
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 64 (ESTIMATED)
- **Why stopped:** toxicity
- **Last updated:** 2009-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161239, "LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT00161239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*